View More View Less
  • 1 Department of Infectology, 1st Department of Internal Medicine, University of Pécs, Pécs, , Hungary
  • | 2 Department of Gastroenterology, 1st Department of Internal Medicine, University of Pécs, Pécs, , Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Dramatic changes in the epidemiology of Clostridium difficile infections have been reported from the western world in the past decade. The proportion of severe cases is significantly elevating and clinicians now have to contend with the problem of additional and more frequent episodes of recurrences including an upward trend in the mortality rate. This situation led us to investigate the possibility of the fecal microbiota transplantation (FMT). An amount of 100 ml of fecal microbiota solution was instilled into a nasojejunal (NJ) tube in 16 cases and into a nasogastric (NG) tube in 44 cases. In all of the cases, where the solution was instilled via nasojejunal tubes, the symptoms resolved within 24 h. We did not note any recurrences in this group. When the material was flushed in through nasogastric tubes, the symptoms resolved in 39 (88.64%) cases within 24 h. In this group, we have experienced a recurrent episode of C. difficile infection in five (11.36%) cases. Three of them were cured with a second transplantation. We have found that in our practice the upper gastrointestinal tract methods had the primary cure rate of 91.67%, whereas the secondary cure rate is 96.67%. When we compared the NJ and NG methods, we have found that the differences in the outcomes are not significant statistically (p = 0.3113 using Fisher’s exact probability test). In conclusion, FMT proved to be very effective, particularly in recurrent infections and in cases where conventional treatment had failed.

  • 1.

    Hall, I. C., O’Toole, E.: Intestinal flora in newborn infants: With a description of a new pathogenic anaerobe, Bacillus difficile. Am J Dis Child 49, 390402 (1935).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Larson, H. E., Price, A. B., Honour, P., Borriello, S. P.: Clostridium difficile and the etiology of pseudomembranous colitis. Lancet 1, 10631066 (1978).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    McDonald, L., Owings, M., Jernigan, D.: Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Inf Dis 12, 409415 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Lucado, J., Gould, C., Elixhauser, A.: Clostridium difficile infections (CDI) in hospital stays. Healthcare cost and utilization project. Agency for healthcare Research and Quality. Statistical brief # 124. Available at http://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf. Accessed on: March 27, 2012.

    • Search Google Scholar
    • Export Citation
  • 5.

    Muro, C. A., Pokrywka, M., Shutt, K., Mendelshon, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystofiak, S., Patel-Brown, S., Pasculle, A. W., Paterson, D. L., Saul, M., Harrison, L. H.: A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidmiol 26, 273280 (2005).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Rholke, F., Stollman, F.: Fecal microbiota transplantation in relapsing Clostridium difficile infection. Ther Adv Gastroenterol 516, 403420 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Eisemann, B., Silen, W., Bascom, G., Kauvar, A.: Fecal enema as an adjunct in the treatment of pseudomembraneous enterocolitis. Surgery 44, 854859 (1958).

    • Search Google Scholar
    • Export Citation
  • 8.

    Borody, T. J., Warren, E.F., Leis, M. S., Surace, R., Ashman, O., Siarakas, S.: Bacteriotherapy using fecal flora. Toying with human motions. J Clin Gastroenterol 38, 475483 (2004).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Debast, S. B., Bauer, M. P., Kuijper, E. J.: European Society of Clinical Microbiology and Infectious Diseases: Update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 20, 126 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A.N., Curry, S.R., Gilligan, P.H., McFarland, L.V., Mellow, M., Zuckerbraun, B. S.: Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108, 478498 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., Moore, T. A., Russell, G., Surawicz, C.: Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 12, 10441049 (2011).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Gustaffson, A., Lund-Tonnensen, S., Berstad, A., Midtvedt, T., Norin, E.: Faecal short-chain fatty acids in patients with antibiotic associated diarrhea, before and after fecal enema treatment. Scand J Gastroeneterol 33, 721727 (1998).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Gustaffson, A., Berstad, A., Lund-Tonnensen, S., Midtvedt, T., Norin, E.: The effect of fecal enema on five microflora associated characteristics in patients with antibiotic associated diarrhea. Scand J Gastroenterol 34, 580586 (1999).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Brandt, L., Aroniadis, O., Mellow, M., Kanatzar, A., Kelly, C., Park, T., Stollman, N., Rohlke, F., Surawicz, C.: Long term follow up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107, 10791087 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Mattila, E., Uusitalo-Seppala, R., Wuorela, M., Lehtola, L., Nurmi, H., Ristikankare, M., Moilanen, V., Salminen, K., Seppälä, M., Mattila, P. S., Anttila, V. J., Arkkila, P.: Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 142, 490496 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Garborg, K., Waagsbo, B., Stallemo, A., Matre, J., Sundoy, A.: Results of fecal donor installation therapy for recurrent Clostridium difficile associated diarrhea. Scan J Infect Dis 42, 857861 (2010).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Nieuwdorp, M., van Nood, E., Speelman, P., van Heukelem, H. A., Jansen, J. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F., Keller, J. J.: Treatment of recurrent Clostridium difficile associated diarrhea with a suspension of donor feces. Ned Tijdschr Geneeskd 152, 19271932 (2008).

    • Search Google Scholar
    • Export Citation
  • 18.

    Rubin, T., Gessert, C., Aas, J.: Stool transplantation for older patients with Clostridium difficile infection. J Am Geriatr Soc 57, 23862387 (2009).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F., Tijssen, J. G., Speelman, P., Dijkgraaf, M. G., Keller, J. J.: Duodenal infusion of donor feces for recurrent Clostridium difficile. New Eng J Med 368, 407415 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Aas, J., Gessert, C. E., Bakken, J. S.: Recurrent Clostridium difficile colitis: A case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 36, 580585 (2003).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., Wilcox, M. H.: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31, 431455 (2010).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Nagy, G. G., Várvölgyi, Cs., Balogh, Z., Orsi, P., Paragh, G.: Detailed recommendation for the methodology of fecal transplantation used for treatment of Clostridium difficile associated diarrhoea. Orv Hetil 154, 1019 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
submission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2021 9 0 0
Jul 2021 22 0 0
Aug 2021 9 0 0
Sep 2021 13 0 0
Oct 2021 13 1 1
Nov 2021 8 0 0
Dec 2021 0 0 0